NeuroBo Pharmaceuticals Inc (NRBO)
4.60
+0.36
(+8.49%)
USD |
NASDAQ |
May 16, 16:00
4.60
0.00 (0.00%)
After-Hours: 20:00
NeuroBo Pharmaceuticals Max Drawdown (5Y): 99.99% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.99% |
| March 31, 2024 | 99.99% |
| February 29, 2024 | 99.99% |
| January 31, 2024 | 99.99% |
| December 31, 2023 | 99.99% |
| November 30, 2023 | 99.99% |
| October 31, 2023 | 99.99% |
| September 30, 2023 | 99.99% |
| August 31, 2023 | 99.99% |
| July 31, 2023 | 99.99% |
| June 30, 2023 | 99.99% |
| May 31, 2023 | 99.99% |
| April 30, 2023 | 99.99% |
| March 31, 2023 | 99.99% |
| February 28, 2023 | 99.99% |
| January 31, 2023 | 99.99% |
| December 31, 2022 | 99.99% |
| November 30, 2022 | 99.98% |
| October 31, 2022 | 99.92% |
| September 30, 2022 | 99.92% |
| August 31, 2022 | 99.92% |
| July 31, 2022 | 99.92% |
| June 30, 2022 | 99.92% |
| May 31, 2022 | 99.92% |
| April 30, 2022 | 99.89% |
| Date | Value |
|---|---|
| March 31, 2022 | 99.86% |
| February 28, 2022 | 99.86% |
| January 31, 2022 | 99.81% |
| December 31, 2021 | 99.77% |
| November 30, 2021 | 99.71% |
| October 31, 2021 | 99.66% |
| September 30, 2021 | 99.48% |
| August 31, 2021 | 99.48% |
| July 31, 2021 | 99.48% |
| June 30, 2021 | 99.48% |
| May 31, 2021 | 99.48% |
| April 30, 2021 | 99.41% |
| March 31, 2021 | 99.25% |
| February 28, 2021 | 99.19% |
| January 31, 2021 | 99.05% |
| December 31, 2020 | 99.05% |
| November 30, 2020 | 99.05% |
| October 31, 2020 | 99.05% |
| September 30, 2020 | 98.97% |
| August 31, 2020 | 98.85% |
| July 31, 2020 | 98.83% |
| June 30, 2020 | 98.70% |
| May 31, 2020 | 98.70% |
| April 30, 2020 | 98.70% |
| March 31, 2020 | 98.70% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.20%
Minimum
May 2019
99.99%
Maximum
Feb 2023
99.35%
Average
99.69%
Median
Max Drawdown (5Y) Benchmarks
| Eli Lilly and Co | 22.48% |
| SIGA Technologies Inc | 82.20% |
| Vanda Pharmaceuticals Inc | 89.11% |
| Tenon Medical Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.91% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -78.15 |
| Beta (5Y) | -0.2343 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 106.1% |
| Historical Sharpe Ratio (5Y) | -0.7609 |
| Historical Sortino (5Y) | -1.378 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 50.11% |